IP Library Patent Application 18945913
Patent Application
App. No. 18/945,913

METHODS AND COMPOSITIONS FOR CAPPING NUCLEIC ACIDS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/945,913
Abstract

A method for identifying a nucleic acid template that include (a) providing a plurality of primer-template hybrids, wherein a first hybrid of the plurality includes a first template hybridized to a first primer, and wherein a second hybrid of the plurality includes a second template hybridized to a second primer, the second primer having a ternary complex inhibitor moiety at the 3′ end; (b) delivering polymerases and nucleotides to the plurality, whereby the first hybrid binds a polymerase and nucleotide to form a stabilized ternary complex and whereby the second hybrid does not bind a polymerase and nucleotide to form a stabilized ternary complex; and (c) detecting the stabilized ternary complex to identify the first template.

Claims (23)

1 .- 28 . (canceled)

29 . An apparatus, comprising a plurality of primer-template nucleic acid hybrids, wherein a first subset of the primer-template nucleic acid hybrids comprises a blocked nucleotide at the 3′ end of the primer, and wherein a second subset of the primer-template nucleic acid hybrids comprises a ternary complex inhibitor at the 3′ end of the primer.

30 . The apparatus of claim 29 , wherein the blocked nucleotides comprise reversibly terminated nucleotides.

31 . The apparatus of claim 29 , wherein the plurality of primer-template nucleic acid hybrids is attached to a solid support.

32 . The apparatus of claim 31 , wherein the solid support comprises a nucleic acid array.

33 . The apparatus of claim 31 , wherein the plurality of primer-template nucleic acid hybrids is attached to a feature of the array and wherein the templates that are attached to the feature comprise the same sequence.

34 . The apparatus of claim 29 , wherein the plurality of primer-template nucleic acid hybrids is in a manufactured vessel.

35 . The apparatus of claim 34 , wherein the manufactured vessel comprises a flow cell.

36 . The apparatus of claim 29 , wherein primer-template nucleic acid hybrids in the first subset are each bound to a polymerase and cognate nucleotide, thereby forming ternary complexes.

37 . The apparatus of claim 36 , wherein the polymerase is covalently attached to an exogenous label.

38 . The apparatus of claim 36 , wherein the cognate nucleotide is covalently attached to an exogenous label.

39 . The apparatus of claim 36 , wherein the exogenous label comprises a fluorophore.

40 . The apparatus of claim 29 , wherein the primers of the first subset of the primer-template nucleic acid hybrids are the same length.

41 . The apparatus of claim 40 , wherein the primers of the second subset of the primer-template nucleic acid hybrids differ in length.

42 . The apparatus of claim 40 , wherein the primers of the second subset of the primer-template nucleic acid hybrids are shorter than the primers of the first subset of the primer-template nucleic acid hybrids.

43 . The apparatus of claim 40 , wherein the primers of the second subset of the primer-template nucleic acid hybrids are longer than the primers of the first subset of the primer-template nucleic acid hybrids.

44 . The apparatus of claim 29 , wherein the number of primer-template nucleic acid hybrids in the first subset is less than 50% of the number of primer-template nucleic acid hybrids in the plurality.

45 . The apparatus of claim 29 , wherein the ternary complex inhibitor comprises an oligonucleotide moiety.

46 . The apparatus of claim 29 , wherein the ternary complex inhibitor comprises a moiety that inhibits polymerase from binding at the 3′ end of the primer.

47 . The apparatus of claim 29 , wherein the ternary complex inhibitor comprises a moiety that inhibits cognate nucleotide from binding to a polymerase at the 3′ end of the primer.

48 . A system comprising:

(a) the apparatus of claim 29 ; and

(b) a detector configured to detect the plurality of primer-template nucleic acid hybrids.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2026
From: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 075466/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2025
From: SUBRAMANIAN, HARI K.K.; FLEISCHER, CHAD; MALYSHEV, DENIS
To: OMNIOME, INC.
Reel/Frame 070104/0127 →
MERGER Recorded Feb 4, 2025
From: OMNIOME, INC.
To: OMNIOME, LLC
Reel/Frame 070104/0279 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2025
From: OMNIOME, LLC
To: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Reel/Frame 070104/0416 →